Condition: Opioid Withdrawal · Opioid Use Disorder · Sponsor: Spark Biomedical, Inc.
The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.
This description comes directly from the study's public registry record.
Caroline Benner · (210) 624-8046 · clinicaltrials@sparkbiomedical.com
Brooke Le
Always discuss trial participation with your own doctor first.
| Hazelden Betty Ford Foundation | Center City, Minnesota, United States | Recruiting |
| Battelle Memorial Institute | Columbus, Ohio, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06487533